If you don’t get tested, you won’t know

Left untreated, STIs can have serious long-term consequences and can harm your reproductive system and overall health. Pelvic Inflammatory Disease (PID)4 is a serious infection of the female reproductive system which includes the womb, fallopian tubes, and ovaries. Although there are no obvious symptoms,5 PID increases your risk of:

• Internal abscesses
• Chronic pelvic pain
• Tubal or ectopic pregnancy (i.e., when a pregnancy occurs
  outside of the uterus, which can be fatal for the woman)
• Miscarriage or loss of early pregnancy
• Inflammation of the uterine lining following childbirth
• Infertility

Curable, but not harmless

The good news is that most STIs are easily cured—if you take the right, highly specific, antibiotic for your particular type of infection.

Chlamydia

is the most common STI caused by a bacteria. Treating chlamydia quickly is critical. It will not repair any damage already done, though.8

Gonorrhea

is also caused by a bacteria. Up to 20% of women infected with gonorrhea develop PID.10 If you’re pregnant but go untreated, your baby can be infected during childbirth.11

Trichomoniasis

(or “trich”) is a very common STI caused by a parasite, and 70% of infected persons don’t develop any symptoms. Untreated infections can last from months to years.13 Other effects include increasing the risk of contracting HIV by two to three times and giving birth to infants who are small for their gestational age.

Schedule Your Appointment & Get Your Testing, Results, Treatment & Consultation In ONE Visit

We’re here to all your questions

What is the Visby Medical Sexual Health Test?

The Visby Medical Sexual Health Test is a single-use, fully-integrated, rapid, automated polymerase chain reaction (PCR) in-vitro diagnostic test for the qualitative detection and differentiation of DNA from Chlamydia, Gonorrhea, Trichomoniasis infections.

What type of test is the Visby Medical Sexual Health Test?

The Visby Medical Sexual Health Test is a single-use (disposable), fully-integrated, automated Polymerase Chain Reaction (PCR) in vitro diagnostic test intended for use in point-of-care or clinical laboratory settings for the rapid detection and differentiation of DNA from Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) in self-collected female vaginal swab specimens collected in Visby Medical Collection Media in a health care setting. The test results are to aid in the diagnosis of symptomatic or asymptomatic infections with CT, NG, and TV.

Who can use the Visby Medical Sexual Health Test?

The Visby Medical Sexual Health Test is intended for use with vaginal samples from women, aged 14 years of age or older.

Will I need a prescription to use this test?

Yes, the Visby Sexual Health Test will only be available in CLIA-waived point-of-care settings with a prescription, such as a clinician’s office.

Why does the Visby Medical Sexual Health Test include these three infections?

• As a diagnostic company, we understand that chlamydia and gonorrhea are currently two of the most widely spread STIs, making their quick diagnosis and treatment of high importance.
  • Furthermore, STIs are frequently asymptomatic, with nearly 50% of gonorrhea cases and 80% of chlamydia cases being asymptomatic in women.
• Currently, there is no reporting requirement for trichomoniasis by public health authorities, meaning that there might be a significant under diagnosis and reported numbers of this STI.
  • This is especially concerning as trichomoniasis has been identified to increase risk of contracting HIV two- to three-fold, raising the need for tracking and treating much more important over the last several years.
  • Also, approximately 70% of all trichomoniasis cases are asymptomatic.
• A 2019 KFF poll found that a large share of the public is unaware of how common STIs are, with far less than half (36%) aware that STI rates are increasing every year.